Mortality and use of angiotensin-converting enzyme inhibitors in COVID 19 disease: a systematic review

BACKGROUND: Interest exists concerning the use of angiotensin-converting enzyme inhibitors (ACEis) in patients with COVID-19 disease. OBJECTIVES: The aim of the study was to perform a systematic review on mortality associated to the use of ACEi in patients with COVID-19 disease. METHODS: Search in M...

Descripción completa

Detalles Bibliográficos
Autor principal: Nunes, José Pedro L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665268/
https://www.ncbi.nlm.nih.gov/pubmed/33204892
http://dx.doi.org/10.1097/j.pbj.0000000000000085

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7665268/
https://www.ncbi.nlm.nih.gov/pubmed/33204892
http://dx.doi.org/10.1097/j.pbj.0000000000000085

Ejemplares similares